期刊文献+

蜜蜂蜂毒主要成分与功能研究进展 被引量:36

Advance on the Main Compositions and the Functions of Honeybee Venom
下载PDF
导出
摘要 蜜蜂蜂毒(honeybee venom)作为重要的蜂产品之一,其中的很多蛋白在抗炎、抗癌、抗菌、抗辐射和杀虫等方面具有很好的效果。20世纪40年代以来,国内外在蜂毒活性成分分析、作用机理、重要基因克隆和毒蛋白功能等方面进行广泛地研究,取得了重要的进展。本文的目的是总结蜜蜂蜂毒主要成分磷脂酶A2、透明质酸酶、蜂毒肽、蜂毒明肽、肥大细胞脱粒肽和镇静肽等毒蛋白的基因结构、生化特性及功能等方面的研究进展,为蜂毒基因的研究和利用提供一定的理论基础。 Honeybee venom is one of important bee products, of which many proteins were identified to play a role in anti-inflammatory, anti-cancer, antimicrobial, anti-radiation, insect disinfestation, and so on. Since 1940s, there had made many significant advances in component analysis, action mechanisms, gene cloning, and protein function analysis of honeybee's venom.i The aim of present review was to summarize the gene structure, biochemical characteristics and function of the main components in honeybee venom, such as phospholipase A2, hyaluronidase, melittin, apamin, mast cell degranulating peptides and secapin. It would will provide the theoretical basis for the research and utilization of honeybee venom.
作者 高丽娇 吴杰
出处 《基因组学与应用生物学》 CAS CSCD 北大核心 2013年第2期246-253,共8页 Genomics and Applied Biology
基金 国家自然科学基金项目(31072092) 国家蜂产业技术体系建设专项(CARS-45)共同资助
关键词 蜜蜂 蜂毒 磷脂酶A2 透明质酸酶 蜂毒肽 Honeybee, Bee venom, Phospholipase A2, Hyaluronidase, Melittin
  • 相关文献

参考文献70

  • 1Argiolas A., and Pisano J.J., 1985,Bombolitins, a new class ofmast cell degranulating peptides from the venom of thebumblebee Megabombus pennsylvanicus, J. Biol. Chem.,260(3): 1437-1444.
  • 2Banks B.E.C., Brown C., Burgess G.M.,Bumstock G.,Claret M.,Cocks T.M., and Jenkinson D.H., 1979, Apamin blocks cer-tain neurotransmitter-induced increases in potassium perme-ability, Nature, 282(5737); 415-417.
  • 3Banks B.E.C., Rumjanek F.D., Sinclair N.M., and Vemon C.A.,1976,Possible therapeutic use of a peptide from the bee ven-om, Bull Inst. Pasteur., 74: 137-144.
  • 4Beard RL.,1963,Insect toxins and venoms, Annu. Rev. Ento-mol., 8: 1-18.
  • 5Buku A., 1999, Mast cell degranulating (MCD) peptide: A proto-typic peptide in allergy and inflammation, Peptides, 20(4):14-20.
  • 6Buku A., and Price J.A., 2001, Further studies on the structural re-quirements for mast cell degranulating (MCD) peptide-medi-ated histamine release, Peptides, 22(12): 1987-1991.
  • 7Chain E.,and Duthie E.S., 1940,Identity of hyaluronidase andspreading factor, Br. J. Exp. Pathol.,21(6): 324-338.
  • 8Dudler T.,Chen W.Q., Wang S.S., Schneider T” Annand R.R.,Dempcy R.O., Crameri R.,Gmachl M.? Suter M.,and Gelb M.
  • 9H.,1992,High-level expression in Escherichia coli and rapidpurification of enzymatically active honey bee venom phos-pholipase A2, Biochim Biophys. Acta., 1165(2): 201-210.
  • 10Eckey R., Menschikowski M., Lattke P., and Jaross W., 1977,Minimal oxidation and storage of low density lipoproteinsresult in an increase susceptibility to phospholipid hydrolysisby phospholipase A2, Atherosclerosis, 132(2): 165-176.

二级参考文献48

共引文献35

同被引文献442

引证文献36

二级引证文献145

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部